CVRx, Inc. Fair Value Adjustment of Warrants
CVRx, Inc. (CVRX) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-10.
Discontinued › Cash Flow
us-gaap:FairValueAdjustmentOfWarrants · last filed 2023-02-10
- CVRx, Inc. fair value adjustment of warrants for the quarter ending 2022-12-31 was $0.00.
- CVRx, Inc. fair value adjustment of warrants for the quarter ending 2022-09-30 was $0.00.
- CVRx, Inc. fair value adjustment of warrants for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- CVRx, Inc. fair value adjustment of warrants for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- CVRx, Inc. fair value adjustment of warrants for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- CVRx, Inc. fair value adjustment of warrants for fiscal 2021 was $13.29M, a 3483.29% increase from fiscal 2020.
- CVRx, Inc. fair value adjustment of warrants for fiscal 2020 was $371.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $0.00 derived: sum of 2 quarters · filed 2023-02-10 | $0.00 derived: sum of 3 quarters · filed 2023-02-10 | $0.00 10-K · filed 2023-02-10 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $0.00 derived: sum of 2 quarters · filed 2022-11-04 | $0.00 10-Q · filed 2022-11-04 | $0.00 derived: sum of 4 quarters · filed 2023-02-10 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $0.00 10-Q · filed 2022-08-01 | $0.00 derived: sum of 3 quarters · filed 2023-02-10 | -$1.85M derived: sum of 4 quarters · filed 2023-02-10 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-02 | $0.00 derived: sum of 2 quarters · filed 2023-02-10 | -$1.85M derived: sum of 3 quarters · filed 2023-02-10 | $9.61M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | -$1.85M derived: sum of 2 quarters · filed 2023-02-10 | $9.61M derived: sum of 3 quarters · filed 2023-02-10 | $13.29M 10-K · filed 2023-02-10 |
| 2021-09-30 | -$1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $9.61M derived: sum of 2 quarters · filed 2022-11-04 | $13.29M 10-Q · filed 2022-11-04 | $14.05M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $11.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $15.14M 10-Q · filed 2022-08-01 | $15.90M derived: sum of 3 quarters · filed 2022-08-01 | $15.53M derived: sum of 4 quarters · filed 2022-08-01 |
| 2021-03-31 | $3.69M 10-Q · filed 2022-05-02 | $4.45M derived: sum of 2 quarters · filed 2022-05-02 | $4.08M derived: sum of 3 quarters · filed 2022-05-02 | |
| 2020-12-31 | $758.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $388.00K derived: sum of 2 quarters · filed 2022-02-22 | $371.00K 10-K · filed 2022-02-22 | |
| 2020-09-30 | -$370.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$387.00K 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | -$17.00K 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |